Journal article
Gefitinib does not improve survival when combined with paclitaxel and carboplatin chemotherapy in people with advanced non-small-cell lung cancer Abstracted from: Herbst RS, Giaccone G, Schiller JH et al. Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: a phase III trial – INTACT 2. J Clin Oncol 2004;22:785–94.
Authors
Evans WK
Journal
Cancer Treatment Reviews, Vol. 30, No. 7, pp. 655–659
Publisher
Elsevier
Publication Date
January 1, 2004
DOI
10.1016/j.ctrv.2004.08.002
ISSN
0305-7372